Open Registry Measuring Impact of Genomic Testing on Treatment Decision After Biopsy in Newly Diagnosed Prostate Cancer Patients
CompletedOBSERVATIONAL
Enrollment
274
Participants
Timeline
Start Date
May 31, 2014
Primary Completion Date
April 15, 2015
Study Completion Date
December 8, 2015
Conditions
Prostate Cancer
Trial Locations (1)
98195
University of Washington, Seattle
All Listed Sponsors
lead
Myriad Genetic Laboratories, Inc.
INDUSTRY
NCT02209584 - Open Registry Measuring Impact of Genomic Testing on Treatment Decision After Biopsy in Newly Diagnosed Prostate Cancer Patients | Biotech Hunter | Biotech Hunter